5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature

Acta Neurochirurgica

Volumn 155, Issue 6, 2013, Pages 965-972

  Della Puppa, Alessandro ^a   De Pellegrin, Serena ^a   D'Avella, Elena ^a   Gioffrè, Giorgio ^a   Rossetto, Marta ^a   Gerardi, Alessandra ^a   Lombardi, Giuseppe ^b   Manara, Renzo ^c   Munari, Marina ^a   Saladini, Marina ^a   Scienza, Renato ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Cortical and sub cortical stimulation; Eloquent areas; Fluorescence guided tumor resection; Functional mapping; High grade glioma; Intra operative monitoring; Neuronavigation

Indexed keywords

AMINOLEVULINIC ACID; DEXAMETHASONE;

5 AMINOLEVULINIC ACID FLUORESCENCE GUIDED SURGERY; ABSENCE OF SIDE EFFECTS; ADULT; AGED; CLINICAL ARTICLE; COMPLETE RESECTION OF ENHANCING TUMOR; DIFFUSION TENSOR IMAGING; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; GLIOMA; GROSS TOTAL RESECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MALE; MORBIDITY; NEUROLOGIC DISEASE; NEUROSURGERY; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH;

ADULT; AGED; AMINOLEVULINIC ACID; BRAIN MAPPING; BRAIN NEOPLASMS; FLUORESCENCE; GLIOMA; HUMANS; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOPLASM GRADING; NEUROSURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84878771805     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-013-1660-x     Document Type: Review

References (21)

1. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198 (Pubitemid 32799739)
2. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-764
3. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013 (Pubitemid 32800611)
4. Senft C, Forster MT, Bink A, Mittelbronn M, Franz K, Seifert V, Szelényi A (2012) Optimizing the extent of resection in eloquently located gliomas by combining intraoperative MRI guidance with intraoperative neurophysiological monitoring. J Neurooncol 109(1):81-90. doi: 10.1007/s11060-012-0864-x. Epub 2012 Apr 17
5. Idoate MA, Díez Valle R, Echeveste J, Tejada S (2011) Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence. Neuropathology 31(6):575-582. doi: 10.1111/j.1440-1789.2011.01202.x. Epub 2011 Mar 1
6. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392-401
7. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T, ALA-Glioma Study Group (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564-576
8. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65(3):463-469, discussion 469-70
9. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42(5):1044-1055, discussion 1055-6 (Pubitemid 28196516)
10. Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-ALA intraoperative fluorescence imaging and brain mapping. Neurosurgery. doi: 10.1227/NEU. 0b013e31826d1e6b
11. Duffau H, Capelle L, Sichez JP, Faillot T, Abdennour L, Law Koune JD, Dadoun S, Bitar A, Arthuis F, Van Effenterre R, Fohanno D (1999) Intraoperative direct electrical stimulations of the central nervous system: the Salpêtrière experience with 60 patients. Acta Neurochir 141:1157-1167
12. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V (1989) The Canadian neurological scale: validation and reliability assessment. Neurology 39:638-643 (Pubitemid 19126958)
13. Rapp B (ed) (2001) A handbook of cognitive neuropsychology what deficits reveal about the human mind/brain. Psychology Press, Philadelphia
14. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191-205
15. Butowski N, Lamborn KR, Berger MS, Prados MD, Chang SM (2007) Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neurooncol 85(1):87-94 (Pubitemid 47422661)
16. Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent MJ, Chang SM (2012) Application of novel response/progression measures for surgically delivered therapies for gliomas: Response assessment in neuro-oncology (RANO) working group. Neurosurgery 70(1):234-243, discussion 243-4
17. Díez Valle R, Tejada Solis S, Idoate Gastearena MA, García de Eulate R, Domínguez Echávarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102(1):105-113
18. Feigl GC, Ritz R, Moraes M, Klein J, Ramina K, Gharabaghi A, Krischek B, Danz S, Bornemann A, Liebsch M, Tatagiba MS (2010) Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg 113:352-357
19. De Witt Hamer PC, Robles SG, Zwinderman AH, Duffau H, Berger MS (2012) Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 30(20):2559-2565
20. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L, Lopes M, Mitchell MC, Roche S, Muller JC, Bitar A, Sichez JP, van Effenterre R (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98:764-778 (Pubitemid 36396778)
21. Duffau H, Sichez JP, Lehéricy S (2000) Intraoperative unmasking of brain redundant motor sites during resection of a precentral angioma. Evidence using direct cortical stimulations. Ann Neurol 47:132-135 (Pubitemid 30033663)